157 related articles for article (PubMed ID: 4641788)
1. Use of potassium canrenoate to suppress ouabain-induced ventricular arrhythmias in dogs.
Yeh BK; Sung PK; Saha AK
Circ Res; 1972 Dec; 31(6):915-22. PubMed ID: 4641788
[No Abstract] [Full Text] [Related]
2. Effect of potassium canrenoate on cardiac functions and (Na + + K + )-activated ATPase.
Baskin SI; Akera T; Puckett CR; Brody SL; Brody TM
Proc Soc Exp Biol Med; 1973 Jun; 143(2):495-8. PubMed ID: 4267771
[No Abstract] [Full Text] [Related]
3. Failure of potassium canrenoate to alter experimentally induced digitalis arrhythmias.
Lucchesi BR; Haley NR
Eur J Pharmacol; 1973 Jun; 22(3):256-62. PubMed ID: 4732564
[No Abstract] [Full Text] [Related]
4. Reversal of ouabain-induced electrophysiological effects by potassium canrenoate in canine Purkinje fibers.
Yeh BK; Lazzara R
Circ Res; 1973 Apr; 32(4):501-8. PubMed ID: 4702042
[No Abstract] [Full Text] [Related]
5. Prevention and abolition of ouabain-induced ventricular tachycardia by potassium canrenoate in dogs.
Yeh BK; Sung PK
Eur J Pharmacol; 1972 Aug; 19(2):151-5. PubMed ID: 5071786
[No Abstract] [Full Text] [Related]
6. Potassium canrenoate in the treatment of long-term digoxin-induced arrhythmias in conscious dogs.
deGuzman NT; Yeh BK
Am J Cardiol; 1975 Mar; 35(3):413-20. PubMed ID: 1114999
[TBL] [Abstract][Full Text] [Related]
7. The specificity of potassium canrenoate, a steroidal antidysrhythmic drug.
Yeh BK; Sung PK; Lazzara R
Clin Pharmacol Ther; 1974 Dec; 16(6):1014-22. PubMed ID: 4433469
[No Abstract] [Full Text] [Related]
8. Antiarrhythmic activity of four pteridine compounds in ouabain intoxication.
Yeh BK; Francis JS; Gosselin AJ; Elias RA
Clin Pharmacol Ther; 1975 Feb; 17(2):141-5. PubMed ID: 235395
[TBL] [Abstract][Full Text] [Related]
9. The effects of bretylium on experimental cardiac dysrhythmias.
Allen JD; Zaidi SA; Shanks RG; Pantridge JF
Am J Cardiol; 1972 May; 29(5):641-9. PubMed ID: 5021494
[No Abstract] [Full Text] [Related]
10. The effect of halothane on ventricular automaticity.
Logic JR; Morrow DH
Anesthesiology; 1972 Feb; 36(2):107-11. PubMed ID: 5059098
[No Abstract] [Full Text] [Related]
11. Effect of a spirolactone derivative, sodium canrenoate, on mechanical and electrical activities of isolated rat myocardium.
Coraboeuf E; Deroubaix E
J Pharmacol Exp Ther; 1974 Oct; 191(1):128-38. PubMed ID: 4418463
[No Abstract] [Full Text] [Related]
12. Biologic activity of 16 -methyldichlorisone-17-butyrate in the rat and dog.
Collins EJ; Aschenbrenner J; Nakahama M
Steroids; 1973 Mar; 21(3):443-55. PubMed ID: 4693737
[No Abstract] [Full Text] [Related]
13. The effect of glucagon on arrhythmias due to digitalis toxicity.
Cohn KE; Agmon J; Gamble OW
Am J Cardiol; 1970 Jun; 25(6):683-9. PubMed ID: 4192693
[No Abstract] [Full Text] [Related]
14. Canrenoate in normal man.
Mroczek WJ; Davidov ME; Horoschak A; Finnerty FA
Clin Pharmacol Ther; 1974 Aug; 16(2):336-42. PubMed ID: 4368469
[No Abstract] [Full Text] [Related]
15. Role of vagus in the antagonism of ouabain induced arrhythmias in dogs by beta-adrenoceptor antagonists and related drugs.
Alkondon M; Ray A; Sen P
J Pharm Pharmacol; 1984 Oct; 36(10):702-4. PubMed ID: 6150094
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic activity of the beta-adrenergic blocking agent 1-isopropylamino-3-(3-tolyloxy)-2-propanol (ICI 45763).
Somani P
Am Heart J; 1969 Jan; 77(1):63-71. PubMed ID: 5782851
[No Abstract] [Full Text] [Related]
17. [Effect of a spironolactone, potassium canrenoate, on arrhythmia of the isolated auricle induced by a digitalic drug].
Lamarche M; Royer R
C R Seances Soc Biol Fil; 1971; 165(6):1432-3. PubMed ID: 4262058
[No Abstract] [Full Text] [Related]
18. Antiarrhythmic effects of dichloroisoprenaline, H 56-28, ICI 50172, LB 46, MJ 1999 and propranolol on aconitine-induced atrial and ouabain-induced ventricular arrhythmias.
Hashimoto K; Nakayama K; Oshima T; Kumakura S
Experientia; 1971 Jun; 27(6):666-7. PubMed ID: 4397569
[No Abstract] [Full Text] [Related]
19. ORG 6001 (3alpha-amino-5alpha-androstan-2beta-ol-17-one hydrochloride), a steroidal anti-arrhythmic agent.
Vargaftig BB; Sugrue MF; Buckett WR; van Riezen H
J Pharm Pharmacol; 1975 Sep; 27(9):697-9. PubMed ID: 241815
[No Abstract] [Full Text] [Related]
20. Effects of tiprenolol, practolol and propranolol on experimental ventricular tachyarrhythmias.
Allen JD; Shanks RG
Br J Pharmacol; 1974 Jun; 51(2):179-85. PubMed ID: 4155971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
